What Is the GLAM ETF? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
This guide to the Korea-based Cogi Beauty Skincare & Aesthetics ETF, also known as the GLAM ETF, covers the outlook for the beauty and personal care theme, the characteristics of active management, the absence of a distribution history, and thematic concentration risk. Fee burden and trading conditions are also items to check before holding it for the long term.
What Is the Cogi Beauty Skincare & Aesthetics ETF?
This product is an actively managed exchange-traded fund that invests in companies operating across the beauty, skincare, aesthetics and personal care value chain. Rather than tracking a separate index, the portfolio reflects the manager's own stock selection judgment.
It suits investors who are interested in the growth potential of the consumer goods and aesthetic medicine themes and who can accept sector concentration risk in place of broad market exposure.
It is an ETF run with an active management approach by Cogi Funds.
How Does the Cogi Beauty Skincare & Aesthetics ETF Invest?
| Item | Details |
|---|---|
| Tracking index | No separate tracking index |
| Management style | Active management |
| Rebalancing frequency | Adjusted at the manager's discretion |
| Distribution frequency | No distribution history |
| Total expense ratio | 0.35% |
| Fund type | Equity exchange-traded fund |
The manager looks beyond beauty and skincare brands to companies tied to aesthetic medicine, related equipment, manufacturing, distribution and digital sales channels. Instead of mechanically following index weightings, it builds the portfolio based on each company's business characteristics within the sector and on the manager's judgment.
- A thematic structure that covers the beauty and personal care value chain as a whole
- An active approach that reflects the manager's judgment rather than index tracking
Cogi Beauty Skincare & Aesthetics ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $1.5M, and the total expense ratio is 0.35% per year.
Because the product has a short listing history, liquidity may vary depending on when you trade. Before buying or selling, you should check the bid-ask spread and actual execution conditions yourself.
Cogi Beauty Skincare & Aesthetics ETF Performance and Trends
The fund's performance can be affected by consumer demand related to beauty and personal care, brand competitiveness, demand for aesthetic medicine, and changes in valuations across the sector. Given the nature of active management, stock selection results may also move in a different direction from the broader market.
Fund flows into thematic products can be sensitive to expectations for the consumer economy, sector news and shifts in market risk appetite. For a product with a short track record, it is worth checking how inflows and outflows affect trading conditions.
Cogi Beauty Skincare & Aesthetics ETF Pros and Cons
A clear theme and active stock selection are advantages, but sector concentration, reliance on the manager's judgment and uncertain trading conditions must be weighed as well.
💪 Key Strengths
⚠️ Points to Watch
Cogi Beauty Skincare & Aesthetics ETF Alternative and Related ETFs
No information on comparable listed fund candidates was provided, so we do not directly suggest any specific peer product as an alternative. Instead, it is advisable to distinguish between broad consumer goods exposure, aesthetic medicine exposure and whether a fund is actively managed, and to compare these against your own investment goals. Even within the same consumer theme, holdings scope, sector concentration, fee burden and trading conditions can differ, so you should review the prospectus and the latest disclosures together.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Vanguard Information Technology ETF | $119.17 | +0.5% | $146.8B | 0.09% | 0.4% | +25.1% | |
| State Street Technology Select Sector SPDR ETF | $183.23 | +0.5% | $120.1B | 0.08% | 0.46% | +26.8% | |
| State Street Financial Select Sector SPDR ETF | $55.90 | -1.3% | $52.6B | 0.08% | 1.48% | +6.4% | |
| State Street Health Care Select Sector SPDR ETF | $179.28 | -1.1% | $47.7B | 0.08% | 1.42% | +22.8% | |
| State Street Energy Select Sector SPDR ETF | $69.33 | +2.6% | $44.8B | 0.08% | 2.2% | +55.9% |
Cogi Beauty Skincare & Aesthetics ETF Investor Checkpoints
This product lets you look at the beauty and personal care theme through a single fund, but you should first understand the characteristics of thematic concentration and active management. Before investing, you need to review costs, trading conditions, distribution policy and your own risk tolerance together.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Fee burden | Check cumulative costs over a long holding period and the difference versus similar products | Check disclosure materials |
| Trading conditions | Check the bid-ask spread and the likelihood of actual execution | Check before trading |
| Thematic concentration | Assess whether you can accept concentrated exposure to the beauty and personal care sector | Concentrated exposure |
| Distribution policy | Check the absence of a distribution history and its fit with your cash flow plan | No distribution history |
Changes in the consumer environment, brand competition, demand for aesthetic medicine and related regulatory variables can increase portfolio volatility. A non-diversified structure and active management can widen performance gaps driven by stock selection, and liquidity conditions also deserve attention when trading.
GLAM ETF is a product worth considering if you want actively managed exposure concentrated in the beauty and personal care value chain. However, its concentration and management approach differ from those of broad market products, so you should make your decision after checking the absence of a distribution history, costs and trading conditions, in line with your investment horizon and risk tolerance.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 20, 2026.